New Patent granted in the US

InSingulo is delighted to announce that the company has been granted a patent in the US. The granted patent US 11,346,839 B2 concerns InSingulo´s method for determining the interaction between a ligand and a receptor.

“The US is one of the largest markets, and we are very pleased to strengthen our patent portfolio in this important market”, says Karl-Johan Holm, CEO at InSingulo.